Becton, Dickinson and Company (NYSE:BDX) announces that the U.S. Department of Health and Human Services (HHS) has committed to purchase 2K BD Veritor Plus Systems and 750K rapid SARS-CoV-2 antigen test kits for use on the portable instruments.
Distribution will commence next week.
BDX plans to ramp up production to 2M tests per week by the end of September. It expects to produce up to 10M total tests from now until then.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.